Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy Academic Article uri icon

Overview

MeSH Major

  • Aromatase Inhibitors
  • Breast Neoplasms

abstract

  • Despite suboptimal patient accrual, our results suggest that selected patients with metastatic breast cancer progressing on AI therapy can experience disease stabilisation and a period of observation after AI withdrawal. A randomised phase II trial is planned.

publication date

  • November 25, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4260029

Digital Object Identifier (DOI)

  • 10.1038/bjc.2014.502

PubMed ID

  • 25233398

Additional Document Info

start page

  • 2046

end page

  • 50

volume

  • 111

number

  • 11